In particular, the majority of papillary thyroid carcinomas displayed a 3- to 5-fold decrease of D6/ACKR2 mRNA, while three out of four anaplastic thyroid carcinomas exhibited a 10- to 50-fold decrease of D6/ACKR2 expression (Figure 2). This evidence concerns the gene ACKR2 and differentiated thyroid carcinoma.